Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Localized Resectable Adult Primary Liver Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00040898
What this trial is testing

Sho-Saiko-To Following Removal of Liver Cancer By Embolization in Treating Patients With Liver Cancer That Cannot Be Surgically Removed

Who this might be right for
Liver Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00022334
What this trial is testing

Vaccine Therapy in Treating Patients With Liver Cancer

Who this might be right for
Liver Cancer
Jonsson Comprehensive Cancer Center 33
Testing effectiveness (Phase 2)Study completedNCT02042443
What this trial is testing

Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery

Who this might be right for
Adult CholangiocarcinomaAdvanced Adult Hepatocellular CarcinomaBCLC Stage C Adult Hepatocellular Carcinoma+16 more
National Cancer Institute (NCI) 53
Testing effectiveness (Phase 2)WithdrawnNCT04965714
What this trial is testing

Nivolumab and ADI-PEG 20 Before Surgery for the Treatment of Resectable Liver Cancer

Who this might be right for
Resectable Hepatocellular Carcinoma
M.D. Anderson Cancer Center
Not applicableEnded earlyNCT00087191
What this trial is testing

EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer

Who this might be right for
Advanced Adult Primary Liver CancerCarcinoma of the AppendixFallopian Tube Cancer+68 more
National Cancer Institute (NCI) 30
Not applicableEnded earlyNCT02057874
What this trial is testing

3-Tesla MRI Response to TACE in HCC (Liver Cancer)

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Resectable Adult Primary Liver Cancer+3 more
Vanderbilt-Ingram Cancer Center 2
Testing effectiveness (Phase 2)Ended earlyNCT01239355
What this trial is testing

MK2206 in Treating Patients With Advanced Liver Cancer That Did Not Respond to Previous Therapy

Who this might be right for
Adult Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaLocalized Non-Resectable Adult Liver Carcinoma+1 more
National Cancer Institute (NCI) 15
Large-scale testing (Phase 3)Study completedNCT00363584
What this trial is testing

Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
University Hospital Southampton NHS Foundation Trust 360